Reshaping Implant Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Reshaping Implant Surgery is an evidence-based approach within general and specialist surgery addressing the diagnosis, treatment, and long-term management of patients requiring this form of care. Clinical practice is informed by guidelines from international specialist societies, ensuring patients receive care that is both clinically effective and aligned with individual values and quality-of-life goals.

The management of Reshaping Implant Surgery has evolved substantially with advances in diagnostic precision, pharmacological innovation, minimally invasive techniques, and multidisciplinary care models. Modern treatment is tailored to the individual — incorporating disease severity, comorbidities, age, functional status, and patient preferences — to achieve optimal outcomes while minimising treatment burden. Specialist centres providing Reshaping Implant Surgery offer access to experienced clinicians, advanced technology, and comprehensive multidisciplinary teams proven to improve both safety and effectiveness of care across a range of disease presentations.

International patients seeking Reshaping Implant Surgery at accredited hospitals in India, Thailand, Turkey, and other leading medical tourism destinations benefit from world-class specialist expertise at significantly lower cost than in the USA or UK. All content on MyMedicPlus is reviewed by the Medical Review Board for clinical accuracy and adherence to current evidence-based guidelines.

Reshaping implant surgery addresses a broad range of post-implant issues:

• Capsular contracture (Baker Grade III–IV): Scar tissue around the implant tightens, distorting shape and causing firmness or pain. Requires capsulotomy (release of the capsule) or capsulectomy (complete capsule removal) combined with implant replacement.
• Implant malposition: Includes bottoming out (inferior displacement), lateral displacement, symmastia (implants meeting centrally), or high-riding implants. Corrected by pocket revision, suture techniques, or Acellular Dermal Matrix (ADM) support.
• Implant rupture or deflation: Silicone rupture may be silent (detected by MRI); saline deflation is immediately apparent. Both require implant removal and replacement.
• Asymmetry: Differences in volume, projection, position, or shape between the two sides. Corrected by size exchange, pocket adjustment, or fat grafting to augment a smaller side.
• Aesthetic dissatisfaction: Patient desire for a different size, profile (low/moderate/high), shape (round vs. anatomical/teardrop), or surface texture (smooth vs. textured).
• Breast implant illness (BII) / implant removal: Patients reporting systemic symptoms attributable to implants may request explantation with or without replacement.
• Rippling and wrinkling: Visible or palpable implant folds, particularly with saline implants or in patients with thin tissue coverage. Corrected by plane change, fat grafting, or implant exchange to cohesive gel.

Candidates for reshaping implant surgery should meet the following criteria:

• Previous breast or body implant surgery with documented complication, functional limitation, or aesthetic concern
• Surgical fitness: normal coagulation, absence of active infection, cardiopulmonary clearance for general anaesthesia
• Cessation of smoking for ≥4 weeks preoperatively (smoking significantly increases wound healing complications in revision surgery)
• Stable body weight (weight fluctuation >10 kg can affect outcomes)
• Realistic expectations about achievable results, understanding that revision surgery is often more complex than the primary procedure
• MRI or ultrasound confirmation of implant integrity where rupture is suspected

A complete preoperative assessment includes breast imaging (ultrasound for saline; MRI for silicone rupture screening as recommended by FDA every 5–6 years), review of original operative notes, and detailed discussion of the specific revision goal. Patients with previous radiotherapy to the breast, active systemic illness, or body dysmorphic disorder require specialist psychological assessment before proceeding.

Capsulotomy vs. Capsulectomy

For capsular contracture, scoring or releasing the capsule (capsulotomy) may suffice for mild cases. Grade III–IV contracture requires total capsulectomy — removal of the entire capsule en bloc with the implant — to prevent recurrence. En-bloc capsulectomy is also performed when textured implant-associated lymphoma (BIA-ALCL) is suspected or when BII is the indication.

Implant Exchange

The original implant is removed and replaced with a new device. This may involve changing from saline to cohesive silicone gel, switching from textured to smooth surface, altering volume (cc upsizing or downsizing), or changing profile. The pocket (subglandular, submuscular, or dual-plane) may also be changed to improve coverage or correct malposition.

Pocket Revision with ADM

Acellular Dermal Matrix (ADM, e.g., AlloDerm®, Strattice®) is used as a biologic scaffold to reinforce the lower pole, correct bottoming out, or create a neopocket in a different anatomical plane. It becomes incorporated into the native tissue over 6–12 months.

Fat Grafting as Adjunct

Autologous fat transfer to the surrounding breast tissue can improve coverage over the implant, correct volume asymmetry, and soften transitions in thin patients. Combined in the same operation or as a staged procedure after revision.

Mastopexy (Breast Lift) with Implant Revision

When ptosis coexists with implant complications, a simultaneous mastopexy repositions the nipple-areola complex and reshapes the breast envelope. Increases operative complexity and recovery but avoids a second procedure.

Revision implant surgery, when carefully planned, achieves the following benefits:

• Symptom relief: Capsular contracture revision resolves pain and firmness in over 85% of patients with complete capsulectomy and implant replacement.
• Improved aesthetics: Correction of malposition, asymmetry, or poor shape significantly improves patient-reported satisfaction. Studies report BREAST-Q satisfaction scores comparable to successful primary augmentation after well-executed revision.
• Implant rupture management: Timely removal of a ruptured silicone implant prevents free silicone migration into axillary lymph nodes.
• Updated implant technology: Modern cohesive gel implants offer improved safety profiles versus older generation devices. Patients benefit from transitioning to current-generation devices.
• Resolution of systemic concerns: Patients with BII who opt for explantation report improvement in fatigue, cognitive symptoms, and joint pain in many cases, though causal relationships are not yet fully established by controlled studies.

Revision surgery carries higher complication rates than primary augmentation due to altered tissue planes, scarring, and implant pocket changes:

Common (5–15%)

• Bruising, swelling, and temporary asymmetry during healing
• Seroma or haematoma (fluid or blood collection); may require drainage
• Altered nipple or breast skin sensation, usually temporary

Uncommon (1–5%)

• Wound dehiscence, particularly at the inframammary fold incision
• Implant malposition requiring further revision
• Recurrent capsular contracture (up to 15% at 5 years after secondary revision)
• Implant wrinkling or palpability, especially if tissue coverage is thin

Rare (<1%)

• Implant rupture related to the operative procedure
• Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) — linked exclusively to textured surface implants; risk approximately 1 in 2,800 textured implant recipients
• Deep vein thrombosis or pulmonary embolism (general anaesthesia risk)
• Anaesthetic complications

Patients should report any sudden firmness, pain, swelling, or skin changes to their surgeon without delay.

Immediate Recovery (Days 1–7)

Patients wear a supportive surgical bra continuously for 4–6 weeks. Activity is restricted to light tasks; lifting above shoulder height and vigorous exercise are avoided for 4–6 weeks. Oral antibiotics are prescribed for 5–7 days. Drains, if placed, are removed at 24–48 hours when output is below 30 mL/day.

Short-Term Follow-Up (Weeks 2–6)

Wound check at 10–14 days; sutures are removed or dissolve depending on material. Gentle massage of the implant pockets may be recommended by the surgeon to encourage settling. A supportive (non-underwired) bra replaces the surgical bra at 6 weeks.

Long-Term Monitoring

The FDA recommends MRI surveillance for silicone implants at 5–6 years from surgery and every 2–3 years thereafter, even when asymptomatic. Clinical follow-up at 6 months and 12 months assesses symmetry, capsule status, and patient satisfaction. Patients should be counselled that implants require long-term monitoring throughout their lifetime.

Revision implant surgery is typically more expensive than primary augmentation due to the complexity involved:

• Indication: Capsulectomy with implant exchange is more complex and costly than a straightforward implant size exchange. ADM use adds significant material cost.
• Implant cost: High-cohesion anatomical implants from premium manufacturers (Mentor, Allergan/AbbVie, Sientra) cost more than round smooth implants. Discuss implant selection and its cost implications in advance.
• Surgeon experience: Revision surgery demands advanced training; fee structures reflect this expertise.
• Adjunct procedures: Mastopexy, fat grafting, or concurrent body procedures add to operative time and cost.
• Country of treatment: Clinics in India, Thailand, Mexico, and Turkey offer revision surgery at 40–65% less than US or UK prices, with reputable JCI-accredited centres available. Travel and recovery accommodation must be factored into the total cost for medical tourism.
• Insurance: Medically necessary revisions (rupture, contracture, BIA-ALCL) may be covered by insurance; purely aesthetic changes are generally not covered.

Depending on the indication, the following alternatives may be appropriate before or instead of revision surgery:

• Botulinum toxin or steroid injections into the capsule: For early Grade II capsular contracture, intralesional corticosteroid injections or oral leukotriene antagonists (zafirlukast, accolate) have shown modest benefit in small studies.
• Ultrasound-guided aspiration: For seromas or small haematomas, aspiration under imaging guidance is a non-operative alternative when collections are small and accessible.
• Watchful waiting: Asymptomatic silicone implant rupture (intracapsular) without symptoms may be monitored rather than immediately revised in selected patients, after specialist consultation.
• Implant removal without replacement (explantation): Patients who no longer wish to have implants may choose complete explantation. The native breast tissue may remain suitable or mastopexy may be required for satisfactory aesthetics.
• Fat transfer augmentation: For patients seeking volume correction without a new implant, structured fat grafting provides a natural alternative, though the volume achievable per session is limited to 100–200 mL per breast.